Over the past 5 years, the American Society of Clinical Oncology (ASCO) has supported the development of a Web-based quality-reporting tool in response to a recognized need to provide medical oncologists the opportunity to demonstrate the quality of care that they are providing to patients.
Methods:
The development of quality measures, their basis in the literature, and the descriptions and organizational structure of the measures are discussed.
Results:
Specific results are the property of practices and are not shared outside of the practices except in aggregate. The system allows collection of information concerning a wide range of quality measures in a short period of time. In the last data collection period in the fall of 2008, information was submitted concerning 81 measures of quality divided into one required and six optional modules from over 250 practices concerning 15,000 patients.
Conclusions:
The timely collection of information on a wide range of quality measures regarding cancer patients can be efficiently collected using a Web-based data collection tool allowing for practice self-examination and comparison with other practices.
References
1.
MalinJ.L., SchneiderE.C., EpsteinA.M.. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?J Clin Oncol.2006; 24(4): 626–634.
2.
HewittM., SimoneJ.V., eds. Ensuring Quality Cancer Care.National Cancer Policy Board, Institute of Medicine and Commission on Life Sciences, National Research Council. Washington, DC: National Academy Press;1999.
3.
Developing the Medical Oncology Treatment Plan and Summary.J Oncol Pract2006; 2(2): 95–96.
4.
DonabedianA.. Evaluating the quality of medical care.Milbank Q.2005; 83(4): 691–729.
5.
LuckJ., PeabodyJ.W., DresselhausT.R.. How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record.Am J Med.2000; 108(8): 642–649.
6.
CorriganJ., KohnL., DonaldsonM.. Crossing the Quality Chasm: A New Health System for the 21st Century.Committee on Quality of Health Care in America. Institute of Medicine. Washington, DC: National Academy Press;2001.
7.
HoferT.P., HaywardR.A., GreenfieldS.. The unreliability of individual physician “report cards” for assessing the costs and quality of care of a chronic disease.JAMA.1999; 281(22): 2098–2105.
8.
OkoliC., PawlowskiS.D.. The Delphi method as a research tool: an example, design considerations and applications.Inf Manage.2004; 42(1): 15–29.
9.
American Society of Clinical Oncology (ASCO). Clinical Practice Guidelines.www.asco.org. Accessed April 6, 2009.
10.
National Comprehensive Cancer Network (NCCN).NCCN Clinical Practice Guidelines in Oncology.www.nccn.org. Accessed April 6, 2009.
11.
MiaskowskiC., ClearyJ., BurneyR.. Guideline for the Management of Cancer Pain in Adults and Children.Glenview, IL: American Pain Society;2005.
12.
FioreM.C., JaénC.R., BakerT.B.. Treating Tobacco Use and Dependence: 2008 Update.Rockville, MD: US Department of Health and Human Services; May 2008. www.ahrq.gov/path/tobacco.htm#Clinic. Accessed on March 26, 2009.
13.
Clinical Preventive Services. Revision 6.8, January 2009. Leawood, KS: American Academy of Family Physicians.www.aafp.org/online/en/home/clinical/exam.html. Accessed on March 26, 2009.
AdlerN.E., PageA.E.K.. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs.Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting. Washington, DC: The National Academies Press;2008.
16.
American Society of Clinical Oncology, KrisM.G., HeskethP.J.. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.J Clin Oncol.2006; 24(18): 2932–2947.
17.
RizzoJ.D., SomerfieldM.R., HagertyK.L.. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update.J Clin Oncol.2008; 26(1): 132–149.
18.
LeeS.J., SchoverL.R., PartridgeA.H.. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.J Clin Oncol.2006; 24(18): 2917–2931.
19.
HerringtonJ.D., JaskiewiczA.D., SongJ.. Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.Cancer.2008; 112(9): 2080–2087.
20.
JacobsonJ.O., NeussM.N., McNiffK.K.. Improvement in oncology practice performance through voluntary participation in the Quality Oncology Practice Initiative.J Clin Oncol.2008; 26(11): 1893–1898.
21.
McNiffK.K., NeussM.N., JacobsonJ.O.. Measuring supportive care in medical oncology practice: lessons learned from the Quality Oncology Practice Initiative.J Clin Oncol.2008; 26(23): 3832–3837.
22.
DeschC.E., McNiffK.K., SchneiderE.C.. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures.J Clin Oncol.2008; 26(21): 3631–3637.
23.
McGlynnE.A., AschS.M., AdamsJ.. The quality of health care delivered to adults in the United States.N Engl J Med.2003; 348(26): 2635–2645.
24.
McGlynnE.A., AschS.M., AdamsJ.L.. The Quality of Health Care Delivered to Adults in the United States: Appendix.RAND Health; 2006.
25.
NewcomerL.N.. Insurers and “targeted biologics” for cancer: a conversation with Lee N. Newcomer. Interview by Barbara J. Culliton.Health Aff (Millwood).2008; 27(1): w41–51.
26.
BachP.B., SchragD., BeggC.B.. Resurrecting treatment histories of dead patients: a study design that should be laid to rest.JAMA.2004; 292(22): 2765–2770.
27.
SetoguchiS., EarleC.C., GlynnR.. Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care.J Clin Oncol.2008; 26(35): 5671–5678.
28.
CoscioA.M., AnguianoA., KudererN.M.. Improving quality at a university based hematology/oncology fellowship continuity clinic with the quality oncology practice Initiative (QOPI).J Clin Oncol. 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition).2008; 26 (15S May 20 suppl): 6578. Abstract.
